Business · 06/08/2018Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance for Nonclinical Testing of Orally Inhaled Nicotine-Containing Drug Products
Summary
The Food and Drug Administration has published a draft guidance document outlining nonclinical testing requirements for orally inhaled nicotine-containing drug products, including those for smoking cessation and chronic use.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →